4/5
02:05 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/31
10:45 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Barclays PLC from $40.00 to $8.00. They now have an "overweight" rating on the stock.
Medium
Report
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Barclays PLC from $40.00 to $8.00. They now have an "overweight" rating on the stock.
3/28
04:15 pm
blue
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
High
Report
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
3/28
02:05 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/20
02:06 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/17
03:03 pm
blue
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
3/15
12:50 pm
blue
Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy [Forbes]
Medium
Report
Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy [Forbes]
3/13
03:43 pm
blue
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
Low
Report
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
3/12
02:10 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/11
12:19 pm
blue
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
3/11
01:21 am
blue
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, WBA, BLUE on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, WBA, BLUE on Behalf of Shareholders
3/7
10:36 am
blue
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WBA, IVAC, BLUE on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WBA, IVAC, BLUE on Behalf of Shareholders
3/4
02:09 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/3
01:40 pm
blue
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
2/25
06:07 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Medium
Report
bluebird bio, Inc. (NASDAQ: BLUE) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
2/24
07:22 pm
blue
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
Low
Report
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
2/24
01:26 pm
blue
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Wells Fargo & Company from $40.00 to $5.00. They now have an "equal weight" rating on the stock.
Medium
Report
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Wells Fargo & Company from $40.00 to $5.00. They now have an "equal weight" rating on the stock.
2/24
07:07 am
blue
bluebird bio, Inc. (NASDAQ: BLUE) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.
Low
Report
bluebird bio, Inc. (NASDAQ: BLUE) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.
2/21
03:43 pm
blue
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.
Low
Report
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.
2/21
01:55 pm
blue
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker [CNBC]
Low
Report
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker [CNBC]
2/21
12:30 pm
blue
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of bluebird bio, Inc. - BLUE
Medium
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of bluebird bio, Inc. - BLUE
2/21
12:02 pm
blue
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders
Medium
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders
2/21
09:02 am
blue
Shareholder Alert: Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for its Public Shareholders
Low
Report
Shareholder Alert: Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for its Public Shareholders
2/21
08:52 am
blue
BLUE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of bluebird bio, Inc. Is Fair to Shareholders
Low
Report
BLUE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of bluebird bio, Inc. Is Fair to Shareholders
2/21
07:30 am
blue
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
High
Report
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital